comparemela.com

Latest Breaking News On - Utpal koppikar - Page 2 : comparemela.com

ageas SA/NV (OTCMKTS:AGESY) Upgraded at ING Group

C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Rating) has been assigned a consensus rating of “Hold” from the seven research firms that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. […]

Brokerages Set C4 Therapeutics, Inc (NASDAQ:CCCC) Target Price at $11 86

C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Rating) has been given a consensus recommendation of “Hold” by the seven analysts that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. The […]

Blue Shield names Krishna Ramachandran as Health Transformation Leader

Blue Shield names Krishna Ramachandran as Health Transformation Leader
americanbazaaronline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from americanbazaaronline.com Daily Mail and Mail on Sunday newspapers.

C4 Therapeutics, Inc (NASDAQ:CCCC) Short Interest Update

C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Rating) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 2,830,000 shares, an increase of 7.6% from the March 31st total of 2,630,000 shares. Based on an average trading volume of 572,100 shares, the days-to-cover ratio is currently 4.9 days. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.